SOLENO THERAPEUTICS INC Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Soleno Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Soleno Therapeutics Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.01M, a 1936% increase year-over-year.
  • Soleno Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $7.23M, a 1381% increase year-over-year.
  • Soleno Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was $2.4M, a 626% increase from 2022.
  • Soleno Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was $330K, a 46.6% decline from 2021.
  • Soleno Therapeutics Inc annual Nonoperating Income (Expense) for 2021 was $618K, a 94.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.4M +$2.07M +626% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $330K -$288K -46.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $618K -$11M -94.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $11.7M +$18.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$7.29M -$9.75M -396% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 $2.46M +$3.73M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 -$1.27M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.